Cancer risk among HIV-exposed uninfected children in the United States

被引:0
作者
Horner, Marie-Josephe [1 ]
Hazra, Rohan [2 ]
Barnholtz-Sloan, Jill S. [1 ,3 ]
Shiels, Meredith S. [1 ]
Engels, Eric A. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Extramural Res, Bethesda, MD USA
[3] NCI, Ctr Biomed Informat & Informat Technol, Bethesda, MD 20892 USA
关键词
TRANSMISSION;
D O I
10.1097/QAD.0000000000003458
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In utero exposure to didanosine was associated with increased risk of brain cancer in a French study. We used United States health department records to assess cancer risk among 13 617 children exposed to HIV in utero, who remained HIV-uninfected after birth (1990-2017). Risk of brain tumors was borderline elevated among these children (standardized incidence ratio 2.2, 95% confidence interval 0.8-4.8, P=0.12, based on six cases). Risk was not significantly increased for leukemia or other cancers.
引用
收藏
页码:549 / 551
页数:3
相关论文
共 17 条
[1]  
[Anonymous], 2018, DIDANOSINE
[2]  
[Anonymous], 2012, Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants:programmatic update
[3]  
[Anonymous], 2000, IARC MONOG EVAL CARC
[4]  
[Anonymous], Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
[5]   Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors [J].
Benhammou, Valerie ;
Warszawski, Josiane ;
Bellec, Stephanie ;
Doz, Francois ;
Andre, Nicolas ;
Lacour, Brigitte ;
Levine, Martine ;
Bavoux, Francoise ;
Tubiana, Roland ;
Mandelbrot, Laurent ;
Clavel, Jacqueline ;
Blanche, Stephane .
AIDS, 2008, 22 (16) :2165-2177
[6]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[7]  
Evans Ceri, 2016, Lancet Infect Dis, V16, pe92, DOI 10.1016/S1473-3099(16)00055-4
[8]   Monitoring death and cancer in children born to HIV-infected women in England and Wales: use of HIV surveillance and national routine data [J].
Hankin, Claire ;
Lyall, Hermione ;
Peckham, Catherine ;
Tookey, Pat .
AIDS, 2007, 21 (07) :867-869
[9]   Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine [J].
Hanson, IC ;
Antonelli, TA ;
Sperling, RS ;
Oleske, JM ;
Cooper, E ;
Culnane, M ;
Fowler, MG ;
Kalish, LA ;
Lee, SS ;
McSherry, G ;
Mofenson, L ;
Shapiro, DE .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (05) :463-467
[10]   Risk of cancer in children exposed to didanosine in utero [J].
Hleyhel, Mira ;
Goujon, Stephanie ;
Delteil, Clemence ;
Vasiljevic, Alexandre ;
Luzi, Stephanie ;
Stephan, Jean-Louis ;
Reliquet, Veronique ;
Jannier, Sarah ;
Tubiana, Roland ;
Dollfus, Catherine ;
Faye, Albert ;
Mandelbrot, Laurent ;
Clavel, Jacqueline ;
Warszawski, Josiane ;
Blanche, Stephane .
AIDS, 2016, 30 (08) :1245-1256